This looks to us as a COI -- there is inducement to recruit individuals for
whom the study is not necessarily the best therapy.

Chuck

At 02:03 PM 10/21/2002 -0500, you wrote:
>Does anyone have a policy they would be willing to share regarding the
>acceptance (or rejection) of bonus or incentive payments from
>pharmaceutical companies for accelerated recruiting in clinical trials?
>
>Thanks,
>Jennifer
>
>Jennifer Sharp, J.D.
>Legal and Human Protections Administrator
>Arkansas Children's Hospital Research Institute
>1120 Marshall Street
>Little Rock, AR  72202
>501-364-3571
>501-364-2705 (Fax)
>
>
>======================================================================
>  Instructions on how to use the RESADM-L Mailing List, including
>  subscription information and a web-searchable archive, are available
>  via our web site at http://www.hrinet.org (click on "Listserv Lists")
>======================================================================

Herbert B. Chermside, CRA
Director, Sponsored Programs Administration
Virginia Commonwealth University
PO BOX 980568
Richmond, VA  23298-0568
Express Delivery Only:
 Sanger Hall, Rm. 1-032A
 11th & Marshall Streets
 Richmond, VA  23219
Voice:  804-828-6772
Fax     804-828-2521
OFFICE e-mail   xxxxxx@VCU.EDU
Personal e-mail xxxxxx@vcu.edu
http://views.vcu.edu/ospa/
VCU will close most faculty and staff offices from December 21, 2002
through January 5, 2003.  OSPA will operate only a skeleton staff, with
some limited hours, during this period.

======================================================================
 Instructions on how to use the RESADM-L Mailing List, including
 subscription information and a web-searchable archive, are available
 via our web site at http://www.hrinet.org (click on "Listserv Lists")
======================================================================